Stanley Estime, MSCI QA/QI Specialist January 17, 2013 Reportable New Information.

Slides:



Advertisements
Similar presentations
The Role of the IRB An Institutional Review Board (IRB) is a review committee established to help protect the rights and welfare of human research subjects.
Advertisements

The HRPP FYI Process and the UPIRSO/SAE Review Sheet An IRB Infoshort February 2014.
Electronic Submission Tracking & Reporting - IRB Investigator/Staff Lab Session Training QIP Ed Series.
Research Coordination Guidance The Committees on Human Research Serving University of Vermont & Fletcher Allen Health Care
SOP Melody Lin, Ph.D. Deputy Director, Office for Human Research Protections Director, International Activities Santiago, Chile August.
Unanticipated Problems Involving Risk to Subjects or Others (UPIRSO) Roy R. Estrada, PhD, PA-C, CIP Associate Director IRB UTHSCSA.
UTHSC IRB Donna Hollaway, RN, CCRC 11/30/2011 Authority to Audit 45 CFR (e) An IRB shall conduct continuing review of research covered by this.
USF Research Integrity & Compliance eIRB Comprehensive Training 10/07/2014.
IRB Determinations 1. AAHRPP Site Visit Results Site visitors observed a real commitment to human subject protections Investigator and research staff.
Exempt Research Mary Banks BS, BSN IRB Director CRC IRB and BUMC IRB.
Pharmacists Responsibilities in Clinical Studies Mike R Sather, PhD Crystal L Harris, PharmD February 26, 2004.
John Naim, PhD Director Clinical Trials Research Unit
IRB 101: Informed Consent Columbia University Medical Center IRB September 22, 2005.
IRB-Investigator/ Research Coordinator Mtg. “CUMC’s New Progressive Policy For Adverse Event Reporting” April 13, 2004 George Gasparis Andrew Wit, Ph.D.
Columbia University IRB IRB 101 September 21, 2005 George Gasparis, Executive Director, CU IRB Asst. V.P. and Sr. Asst. Dean for Research Ethics.
CUMC IRB Investigator Meeting Human Subjects Research Non-Compliance September 15, 2005.
Human Research Protection Program Training: Post-Approval Event Reporting March 26, 2008 Lisa Voss, MPH, CIP Assistant Director, QIU Human Research Protection.
Renewing An Approved Protocol: IRB Review Process
Unlocking the Mystery of General Information Reporting Research Compliance Administration Training Presentation Wednesday, June 6, 2007 Presenter:Heather.
Stanley Estime, MSCI December 9, 2014 Record Keeping: What is Regulatory Documentation and how should it be maintained? Tel:
Institutional Review Board (IRB) Human Subject Research Office (HSRO) University of Miami and Affiliated Institutions.
Continuing Review VA Requirements Kevin L. Nellis, M.S., M.T. (A.S.C.P.) Program Analyst Program for Research Integrity Development and Education (PRIDE)
Federalwide Assurance Presentation for IRB Members.
Using Technology to Strengthen Human Subject Protections Patricia Scannell Director, IRB Washington University School of Medicine.
New IRB Guideline Changes and Converting to eIRB - Suggestions for Maintaining Compliance. Ramesh Ghodgaonkar, BPHARM, MSITS, MSB, MBA Betsy Johnson, BA.
Reporting Unanticipated Problems and Adverse Events: A Change in Policy Mary A. Banks RN, BS, BSN Director, BUMC IRB Wednesday, November 14, 2007.
Unanticipated Problems Potentially Involving Risks to Subjects or Others Research Protections Office Serving UVM and FAHC Updated April 2012.
Reporting Adverse Events and Unanticipated Problems to the UAB IRB Policy and Procedure Change September 22, 2006 Amanda G. Murphy, RN, CIP Assistant Director,
Sara Brand Associate Director Research Compliance Administration.
Common Audit Findings UTHSC Institutional Review Board (IRB)
Michelle Groy Johnson Quality Improvement Officer Research Integrity Office Tough Love: Understanding the Purpose and Processes of Quality Assurance.
Adverse Event/Unanticipated Problems Policy and Procedures November 2007.
University of Miami Office of Research Compliance Assessment Lynn E. Smith, JD, CIM, CIP Johanna Stamates, RN, BA, CCRC With assistance from Elizabeth.
Research Auditing Presented by: Darlene Krueger, MBA RN CCRA Chief, GCP Auditing & Training VA Cooperative Studies Program Albuquerque, NM.
Monitoring IRB Monitoring of Clinical Trials. Types of Monitoring Internally Internally Externally Externally.
JERI R. BARNEY, JD HRPP COMPLIANCE MANAGER YALE UNIVERSITY HUMAN RESEARCH PROTECTION PROGRAM DECEMBER 13, 2012 Noncompliance.
VHA Handbook “Research Compliance Reporting Requirements” Version: June 15, 2015 ORO Presentation: July 14 and 16, 2015.
Alyssa Speier, MS, CIP QA/QI Education Specialist Stanley Estime, MSCI QA/QI Specialist Interview, Survey, and Focus Group Research: IRB Processes and.
UC DAVIS OFFICE OF RESEARCH Overview of Good Clinical Practices (GCP) Investigator and Study Team Responsibilities Miles McFann IRB Administration Training.
AUDIT REQUIREMENTS, FINDINGS & BASICS RESEARCH COMPLIANCE.
1 Unanticipated problems Melody Lin, Ph.D. December,
Leslie Howes, MPH, CIP Alyssa Speier, MS, CIP September 24, 2014 Investigator Manual: ra/investigator-manual/
Continuing Review Presented by: Karen Jeans, PhD, CCRN, CIP Program Analyst, COACH.
VHA Research Compliance Reporting Requirements ORD Accreditation Conference Call December 15, 2011.
Stanley Estime, MSCI October 19, 2015 Record Keeping: What is Regulatory Documentation and how should it be maintained? Tel:
Ver. 02/13/  Registration  New Studies  Continuing Reviews  Amendments  Reportable Events  Tips & Tricks  Questions 2.
HRPP Policies & Forms Chapter Two Created/Revised for AAHRPP June 1, 2007.
Michelle Groy Johnson Quality Improvement Officer Research Integrity Office Houston, We have a Problem: When and How to Report Problems to the IRB.
Paul Hryvniak MS, CIP Alyssa Speier, MS, CIP September 30, 2014 Student Human Research Education Session Tel:
Avenues of Consent Options available under 45 CFR (d) &
Non-compliance with Human Subjects Research Regulations J. Bruce Smith, MD, CIP November 2014 Continuing Education for IRB Members.
© 2016 University at Buffalo Click Training IRB Module University at Buffalo Office of the Vice President for Research and Economic Development Electronic.
Informed Consent Presented by Marian Serge, RN. Goals Informed consent process and form Title 38 CFR , Common Rule required elements and additional.
Slide 1 Standard Operating Procedures. Slide 2 Goal To review the standard operating procedures Creating the informed consent document Obtaining informed.
IRB reporting updates.
Reportable Events & Other IRB Updates February 2017
Alyssa Speier, MS, CIP November 13, 2013
Regulatory Binder: Maintaining Essential Study Documentation
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
Navigating Non-Compliance
This takes approximately 5 minutes or less from start to finish
Reportable Events & Revised Common Rule
HHS Reporting Requirements and Adverse Events
USF Research Integrity & Compliance
IRB Reporting Requirements & Reportable New Information (RNIs)
Event Reporting in Human Subjects Research
Policy on Prompt Reporting
Research with Human Subjects
Presentation transcript:

Stanley Estime, MSCI QA/QI Specialist January 17, 2013 Reportable New Information

2 Agenda Why is reporting required? Types of Reportable New Information Creating an RNI Submission in ESTR Post Reporting Reporting Scenarios

3 Why is reporting required? DHHS and FDA regulations require that IRBs have: Written procedures for ensuring prompt reporting of any unanticipated problems or serious continuing noncompliance. 21 CFR (b)(1) and 45 CFR (b)(5) New information becomes available during study which may require IRB/Investigator to reassess the risk/benefit to participants

4 Reportable “New” Information Change in Risk/Benefits Adverse Events Findings/Allegations of Regulatory Non-Compliance Audits/Inspections by Federal Agency Protocol Deviations/Violations Breach of Confidentiality Incarceration of Participants Participant Complaints Protocol suspension/termination

5 Reporting Adverse Events Useful to maintain an Adverse Event Tracking log: – Date of Event – Description – Severity – Expectedness* – Relatedness* – Date Reported to the IRB, Sponsor or FDA *A harm is unexpected when its specificity and severity are not reflected in the IRB-approved protocol/consent form. *A harm is possibly related when the research procedures more likely than not caused the harm

6 Report Findings of “Regulatory” Non-compliance Examples include: Conducting human research procedures without IRB approval Failure to obtain informed consent from participants Improper use of a witness during consent process Investigator not maintaining regulatory or participant files Etc…

7 Report Audit Inspection Report any audits by federal agencies: – FDA, OHRP, DOD, VA Pre-Audit Notification  Recommend QIP - Also notify QIP/IRB of any sponsor inquiries which may potentially result in an audit Post Audit Notification  IRB – (i.e. suspension/termination of research by sponsor

8 Report Protocol Deviations/Violations WHO is at fault? Failure to follow protocol due to actions or inactions of investigators, staff, or participants WHAT needs to be reported? Any deviation from the IRB-approved protocol which places participants at increase risk of harm or requires change to the protocol in order to eliminate an apparent hazard to participants

9 Report Breach of Confidentiality For example: A stolen laptop containing identifiable study information or an containing the names of participants inadvertently sent to individuals outside the research team. – Breach information may be damaging to participants’ financial standing, employability, reputation or place participant in criminal or civil liability

10 Report Incarcerations Any participant who is incarcerated during the course of the study for a protocol which has not been previously approved to enroll prisoners

11 Report Participant Complaints “Significant” complaints which impact a participants: – Rights; – Welfare; – Safety; OR – Willingness to participate

12 Reporting Time Frame Within 5 business days from the time the study team became aware of the information Ensure knowledge of Sponsor’s and/or FDA reporting requirements when applicable

13 Reporting Tools Utilize tools to keep track of reporting/ensure proper reporting : – Adverse Event Tracking log – Protocol Violation/Deviation Tracking log

Creating an RNI Submission in ESTR An RNI (Reportable New Information) submission can be created: – From the personal workspace for RNIs NOT associated with a particular study – From the approved study workspace for RNIs related to that specific study Study Workspace: Personal Workspace: 14

RNI Smart Form The RNI Smart Form captures the following information: – Date PI became aware of the information – Categories of the new information (New Risk, Harm, Audit, Researcher Error, Complaint, etc.) – Description of the information – If the new information: Poses a change to the study risk(s) Requires a modification to the approved research 15

RNI Smart Form Tips Question 3: Enter Protocol # as part of description of new information Question 4b: If revisions are required, modification still needs to be separately submitted through the system and is not done in conjunction with RNI Question 5: Users will only be able to link to studies for which they are affiliated with Question 6: Attachments are only used as reference/supporting documents and cannot be “approved” as part of RNI submission. Documents should be attached to Smart Form section via Initial, Continuing, or Modification submission. 16

Post Reporting: RNI Notification To:Stanley Estime Subject:Reportable new information acknowledged Study Link:New Information 12/12/2012 9:59 AM Study Title:New Information 12/12/2012 9:59 AM Principal Investigator: Stanley Estime 17 Notification of Acknowledgement This report of new information has been acknowledged. No further action is required.

18 Reporting Scenarios? During a monitoring visit the following was noticed: 1. Unsigned copies of consent forms on file 2. Dates missing from consent documents 3. Protocol deviations resulting in an adverse event 4. NTF regarding a missing study laptop which was later recovered by HUPD 5. Participant enrolled into the incorrect arm of the study but withdrawn after first study visit Which of the following observations would you report to the IRB as an RNI?

19 When in Doubt? Quality Improvement Program Staff Stanley Estime, Alyssa Speier, Leslie Howes, IRB Operations Staff Paul Hryvniak, Cecelia Grano De Oro, Susan Burnside, Julie Kaberry,